We examined the haemodynamic effects of colloid preload, and phenylephrine and ephedrine administered for spinal hypotension, during caesarean section in 42 women with severe early onset pre-eclampsia. Twenty patients with predelivery spinal hypotension were randomly allocated to receive an initial dose of either 50 lg phenylephrine or 7.5 mg ephedrine; the primary outcome was percentage change in cardiac index. After a 300-ml colloid preload, mean (SD) cardiac index increased from 4.9 (1.1) to 5.6 (1.2) l.min À1 .m À2 (p < 0.01), resulting from an increase in both heart rate, from 81.3 (17.2) to 86.3 (16.5) beats.min À1 (p = 0.2), and stroke volume, from 111.8 (19.0) to 119.8 (17.9) ml (p = 0.049).
Introduction
Two studies have examined the haemodynamic responses to spinal anaesthesia in healthy women during caesarean section using minimally invasive cardiac output monitoring [1, 2] . One of these also compared the haemodynamic responses to the most commonly used vasopressors, phenylephrine and ephedrine, administered to counteract spinal hypotension in healthy women [2] . Overall, these studies concluded that phenylephrine effectively reverses the marked decrease in systemic vascular resistance associated with spinal anaesthesia, and raises systemic vascular resistance and blood pressure, while lowering heart rate and cardiac output to baseline values.
Women with severe pre-eclampsia develop modest afterload reduction during spinal anaesthesia for caesarean section [3] . However, clinically significant hypotension may occur in these high-risk patients, who often have impaired placental function and a compromised fetus. Vasopressor responses during spinal anaesthesia in this group of women have not been formally investigated. Intravenous (i.v.) fluid administration in pre-eclampsia remains controversial. Current opinion suggests that fluid volume expansion is inadvisable unless dihydralazine has been used antenatally, and that i.v. fluid should be restricted to less than 80 ml.h À1 during acute management of the hypertensive patient [4] . The aim of this randomised trial was to compare the maternal cardiac output response to phenylephrine and ephedrine, administered in response to pre-delivery spinal hypotension in parturients with treated severe early onset pre-eclampsia. In addition, the stroke volume response to a colloid preload was recorded.
Methods
The study was conducted at the New Groote Schuur Hospital Maternity Centre in Cape Town, South Africa, with approval from the Health Sciences Faculty Human Research Ethics Committee of the University of Cape Town. Patients with severe early onset preeclampsia (systolic blood pressure > 160 mmHg and/ or diastolic blood pressure > 110 mmHg, on ≥ 2 separate occasions; or symptoms of imminent eclampsia (headache, visual disturbance, epigastric pain) with ≥ 3 + proteinuria [5] ; and gestation ≤ 34 weeks) and a maternal indication for caesarean section, were recruited. We did not recruit patients if they had a contra-indication to spinal anaesthesia; were in active labour; had a BMI > 40 kg.m
À2
; pulmonary oedema; umbilical cord prolapse; previous non-obstetric abdominal surgery; more than two previous caesarean sections; were HIV positive with AIDS-defining disease; had a non-reassuring fetal heart tracing; were < 28 weeks gestation; or had a multiple pregnancy. Informed written consent was taken at least 12 h before operative delivery. Data collection was not continued if spinal anaesthesia could not be established.
Antepartum management followed the established protocol of the hospital. For acute management of preeclampsia, an i.v. cannula was inserted and balanced crystalloid solution administered at < 100 ml.h
À1
. Patients received 4 g magnesium sulphate intravenously, and then 1 g hourly, for seizure prophylaxis. A starting dose of 2.5 mg dihydralazine, repeatable up to four times, was given intravenously to reduce systolic blood pressure to < 160 mmHg. After stabilisation in the acute admission unit, patients were admitted to the ward and allowed free oral fluids. They were started on a maintenance dose of alphamethyldopa 500 mg orally three times daily, and nifedipine 10 mg orally, if systolic blood pressure was > 160 mmHg in the ward. Management was expectant until 34 weeks gestation, or until either the maternal or fetal condition required urgent delivery because of deteriorating renal function, the development of HELLP syndrome (haemolysis, elevated liver enzymes, low platelets) or a non-reassuring fetal heart rate tracing. At 34 weeks gestation, induction of labour was attempted if deemed appropriate by the attending obstetrician. In the event of a failed induction of labour, or if induction of labour was not appropriate, caesarean section was performed. Previous caesarean section was also an indication for elective repeat caesarean section.
In the operating theatre, patients were given 30 ml oral sodium citrate orally and 1 g cefazolin intravenously before induction of spinal anaesthesia. Noninvasive monitoring with electrocardiography, blood pressure and pulse oximetry was then established. A 20-G arterial line was sited on arrival in the operating theatre, and pulse waveform analysis commenced using the LiDCOrapid pulse waveform monitor (LiDCO, London, UK). This employs a pulse power algorithm for beat-by-beat determination of stroke volume. A calibration factor is then applied, using a nomogram incorporating patient-specific characteristics. Data from each consecutive waveform were downloaded to an Excel chart (Microsoft, Redmond, WA, USA).
Baseline haemodynamic values were measured at rest in the left lateral position. Baseline mean arterial pressure was calculated as the mean of two non-invasive blood pressure readings differing by ≤ 10%, taken in the 5 min before induction of spinal anaesthesia. Systemic vascular resistance was calculated assuming a central venous pressure of 5 mmHg. Stroke volume responsiveness was assessed by rapidly administering 300 ml hydroxyethyl starch (Voluven â ; FreseniusKabi, Bad Homburg vor der Höhe, Germany); an increase in stroke volume of > 10% was taken as a positive response. The management of spinal anaesthesia was similar to that described previously [3] . Anaesthesia was performed in the sitting position at the L3/4 interspace, using 2.0-2.2 ml hyperbaric bupivacaine 0.5% with 10 lg fentanyl. After 20 s, the patient was positioned supine with 15°left lateral tilt, using an obstetric wedge, to reduce aortocaval compression. Loss of cold sensation to ethyl chloride spray up to the T4 dermatome was used to define an adequate block, at which point surgery was started. Oxygen 40% was administered by facemask.
Twenty patients were randomly allocated to receive either phenylephrine or ephedrine at the time that a vasopressor was required. Sealed envelopes were preprepared by a statistician, and an anaesthetist not involved with the practical management of the case drew up blinded syringes for use in the event of hypotension. Block randomisation was used, with a block size of two or four using nQuery Advisor Version 6 (Statistical Solutions Ltd, Cork, Ireland). Patients received a 1.5-ml bolus containing either 50 lg phenylephrine or 7.5 mg ephedrine if mean arterial pressure decreased to ≤ 80% baseline and the absolute value was < 110 mmHg. If the mean arterial pressure was not restored to the target value within 60-90 s, a similar or doubled dose of the same vasopressor (50-100 lg phenylephrine; 7.5-15 mg ephedrine) was given. If the target was not achieved after a total of either 300 lg of phenylephrine or 45 mg of ephedrine, the pre-prepared alternative vasopressor could be used. If mean arterial pressure decreased to < 70% baseline, 100 lg phenylephrine or 15 mg ephedrine was given. If heart rate decreased to < 55 beats.min À1 in association with mean arterial pressure < 70% baseline, 10 mg ephedrine was administered, followed by atropine 250-500 lg for persisting bradycardia. A maximum dose of 45 mg ephedrine was allowed.
The primary outcome of the study was the mean difference in cardiac output change following predelivery vasopressor administration. The sample size calculation was based on data from a previous study that examined the peak percentage change in cardiac output after administration of phenylephrine or ephedrine in healthy women [4] . This showed a mean (SD) peak percentage change of À27.8 (10.7)% following phenylephrine and 16 (19.5)% following ephedrine. Assuming an expected between-group difference of 44%, a sample size of five per group would have 90% power using a two-sided test and taking statistical significance as p < 0.05. Due to uncertainty with respect to inter-patient variability, and expected variability in response to vasopressors at the lower doses used in the present study, the sample size was increased to 10 per group. As it was envisaged that approximately 40% of patients would require vasopressor pre-delivery, it was estimated that 50 patients in total might require recruitment.
For analysing the haemodynamic response to the first dose of vasopressor, the pre-vasopressor value was taken as the mean value for the 30-s period before vasopressor administration. The post-vasopressor measurement period lasted 150 s. For each of the time periods of observation, mean values were calculated for each participant. For the post-vasopressor period the mean percentage change from the mean value in the pre-vasopressor period was also calculated for each participant. A two-sample t-test was used to compare the mean values between the groups and the mean percentage differences were also calculated with their 95%CI. Median smooth plots were used to graphically display the mean percentage change in CO in each group at each time-point of the post-vasopressor period, in combination with the profiles at the individual participant level. Similar summary median smooth plots are presented for comparison of cardiac output, mean arterial pressure, systemic vascular resistance, stroke volume and heart rate. In view of the small sample size in the randomised trial, results are expressed as median [range] where appropriate.
Paired t-tests were used to analyse absolute and percentage change in stroke volume in response to the colloid preload. Linear regression analysis was performed to examine the relationship between the change in stroke volume and the change in heart rate after fluid administration. Stata 14 (StataCorp 2015. Stata Statistical Software: Release 14; College Station, TX, USA) was used for statistical analysis.
Results
The trial was conducted between January 2011 and April 2013. Details of patient recruitment are shown in the CONSORT diagram (Fig. 1) . All operative deliveries were for a maternal indication, mostly early onset pre-eclampsia reaching 34 weeks gestation, and/or previous caesarean section. After a total of 42 patients had been recruited, we had included 20 who required vasopressor before delivery, and therefore the trial was concluded. The data from all 42 patients were analysed to determine the response to fluid administration. Mean (SD) cardiac index increased from 4.9 (1.1) to 5. (33%) and 23 (54.8%) patients exhibited a stroke volume response > 10% and > 5%, respectively. In addition, a significant negative correlation was found between the change in stroke volume and change in heart rate in response to fluid loading (dHR = 12.2-0.65 dSV; Pearson's r = À0.67; p < 0.001; Fig. 2 ). The baseline characteristics of the women who received vasopressors were similar between the two groups ( Table 1 ). The median [range] block height was T3 [T2-T6] in both groups. The time from induction of spinal anaesthesia to uterine incision was 18.2 (9.6) min and 17.4 (5.0) min in the phenylephrine and ephedrine groups, respectively. Baseline and pre-vasopressor haemodynamic data are shown in Table 2 . In the 20 patients who developed hypotension, mean cardiac index had increased 0.6 l.min
À1
.m À2 (11.5%; p < 0.0001) at this point, with a corresponding increase in heart rate and decrease in mean arterial pressure and systemic vascular resistance (Table 3) . Table 4 shows the changes in haemodynamic indices in response to vasopressor given during the first hypotensive episode; the dose of phenylephrine was 50 [50-150] lg and ephedrine was 15 [7.5-37.5] mg. The percentage change in cardiac index during the 150-s measurement period was greater, and negative, in patients receiving phenylephrine, at À12.0 (7.3)% vs. ephedrine at 2.6 (6.0)% (p = 0.0001). Figure 3 is a median smooth plot of cardiac output changes in response to vasopressor administration.
The percentage change in heart rate was higher in patients receiving phenylephrine, at À9.1 (3.4)% vs. 5.3 (12.6)% (p = 0.0027), as were changes in systemic vascular resistance, 22.3 (7.5)% vs. À1.9 (10.5)% (p < 0.0001). Figure 4 shows summary median smooth plots of all the haemodynamic variables.
There were no significant differences between the phenylephrine and ephedrine groups in umbilical artery pH, 7 
Discussion
Hypotension after spinal anaesthesia, although less common in women with severe pre-eclampsia than in healthy women [6] , may pose an important clinical challenge, especially in view of fetal compromise in this high-risk group of patients. There are limited studies examining haemodynamic responses to fluids and vasopressors during spinal anaesthesia for caesarean section in early onset severe pre-eclampsia, which may be characterised by higher systemic vascular resistance and lower cardiac output than late onset disease [7, 8] . We found that pre-delivery hypotension after spinal anaesthesia, sufficient to require correction with vasopressors, was associated with a significant increase in maternal cardiac output from the value before spinal anaesthesia. Mean, and not peak, changes in haemodynamic variables in response to vasopressors, were reported in our study, because the mean value was found to be a better summary of the postvasopressor haemodynamic profile, and clear peak values were not demonstrable. The response to phenylephrine was significantly different to ephedrine with respect to systemic vascular resistance, cardiac output and heart rate. Phenylephrine effectively reversed the spinal anaesthesia-induced decrease in systemic vascular resistance, as well as the increase in cardiac output and heart rate. Ephedrine did not significantly change cardiac output. This study suggests that large doses of ephedrine may be necessary to reverse a marked decrease in systemic vascular resistance induced by spinal anaesthesia, and therefore phenylephrine is the first-choice vasopressor in women with early onset severe pre-eclampsia and preserved systolic function. Two studies in healthy term pregnant women, employing minimally invasive beat-by-beat cardiac output monitoring during spinal anaesthesia for caesarean section, showed that spinal anaesthesia is associated with a marked decrease in systemic vascular resistance, hypotension and a partial compensatory increase in cardiac output [1, 2] . In the latter study, there was an initial 36% decrease in systemic vascular resistance and a 23% increase in cardiac output after induction of spinal anaesthesia. Ephedrine 10 mg maintained the pre-vasopressor cardiac output by increasing heart rate. Phenylephrine 80 lg rapidly reversed the spinal anaesthesia-induced changes, with good correlation between cardiac output and heart rate changes [2] . This, and other studies in pre-eclampsia [3, 9] , suggest that the haemodynamic effects of phenylephrine are similar to those in healthy women. Current guidelines for fluid management in preeclampsia advise against i.v. volume expansion in untreated patients, and suggest maintenance fluid of < 80 ml.h À1 [4] . We found variable stroke volume responsiveness to a colloid preload in this series of patients. This suggests that fluid restriction is advisable unless individualised monitoring is used. An inverse relationship between stroke volume response and change in heart rate may also indicate that fluid should be discontinued if heart rate increases during administration of a fluid preload. Previous studies using the LiDCO device in obstetric anaesthesia have either used the uncalibrated PulseCO algorithm, which gives a trend in stroke volume, or have derived a calibration factor in the individual case, using a standard dose of i.v. lithium [10] ; the latter would give the most accurate absolute value for stroke volume. Although there is no validation of the LiDCO device in pregnancy, we have found good agreement between the calibrated LiDCO and pulmonary artery catheter-derived cardiac output in patients with complications of severe pre-eclampsia in the immediate postdelivery period [11] . The LiDCOrapid device used in this study employs a calibration factor, based upon a patient-specific nomogram. It is important to note that the device was used in this study as a trend monitor, and to compare drugs, rather than as a measure of absolute values of cardiac output; randomisation should rule out systematic bias. There were some limitations to the study. It was not possible to accurately control pre-operative fluid administration; however, patients were kept nil by mouth overnight before caesarean section, and received < 100 ml.h À1 intravenously if a cannula was in place.
It was difficult to estimate the bolus dose of ephedrine that has an equivalent pressor response to our dose of 50 lg phenylephrine in these women with preeclampsia. We chose to use standard doses of 7.5 mg ephedrine and 50 lg phenylephrine, a ratio of 150:1, based on our usual clinical practice. This is higher than the previously described ratio of 80:1, employed using infusions of these vasopressors in healthy patients [12] .
Despite the higher dose ratio in this study, the magnitude of the effect of ephedrine on systemic vascular resistance was less than that of phenylephrine.
Our results apply specifically to women presenting for caesarean section at 34 weeks gestation, and may differ based on gestational age and severity of preeclampsia. Most patients with severe pre-eclampsia have well-preserved systolic function and cardiac output, as in our study, although diastolic dysfunction is common [13, 14] . However, pulmonary oedema may be associated with severe systolic heart failure [13, 15] , necessitating goal directed haemodynamic management in the individual case. Our results may therefore not apply to patients with severe pre-eclampsia and heart failure with a reduced ejection fraction. This study was not powered to detect betweengroup differences in umbilical cord gases; a further adequately powered study has been completed in this regard, using non-invasive maternal blood pressure monitoring. This showed that fetal acid base status is independent of whether phenylephrine or ephedrine is used to treat spinal hypotension in severe pre-eclampsia with fetal compromise [16] . In conclusion, we found that cardiac output increased in response to spinal anaesthesia in women with severe early onset pre-eclampsia, and that a small dose of phenylephrine reversed the haemodynamic changes more effectively than ephedrine. Phenylephrine is an effective vasopressor in the management of spinal hypotension in patients with severe preeclampsia and preserved left ventricular systolic function. Colloid preload for spinal anaesthesia for caesarean section in treated severe pre-eclampsia was associated with a mean increase in cardiac index, but considerable variability in stroke volume responsiveness, suggesting that fluid restriction is preferable in the absence of cardiac output monitoring.
